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SKELETAL MUSCLE EXHIBITS remarkable malleability, as demonstrated by its ability to adapt to distinct patterns of contractile activity or exercise (7, 12, 70) . Exercise represents a stimulus capable of inducing both acute and chronic adaptive responses, inducing specific changes that serve to minimize cellular stress in subsequent similar exercise sessions (14) . Chronic adaptations to training are likely to represent the summation of each discrete bout of exercise, with these perturbations leading to cumulative alterations in gene and protein expression, and ultimately distinct phenotypic changes (13, 26, 70) . Endurance training elicits metabolic and morphological responses promoting muscle fatigue resistance (13, 25) and includes mitochondrial biogenesis (1, 3, 29) , a fast-to-slow twitch fiber phenotype transformation (70) , a decreased reliance on carbohydratebased fuels during submaximal exercise (28) , and an improved whole body aerobic capacity (V O 2max ; see Ref. 52 ). Molecular events involved in this process include cell signaling pathway activation in response to exercise. These pathways integrate the multitude of inputs from neuromuscular activation, increased intramyocellular Ca 2ϩ , muscle force generation/tension, increased metabolic rates and endocrine/paracrine signals culminating in the appropriate changes in gene and protein expression in the hours after the exercise bout (22) . The importance of understanding these molecular mechanisms driving adaptations to endurance exercise may aid in the development of strategies to prevent the development of insulin resistance, other muscle dysfunction (23) , and enhance exercise performance.
A number of exercise-responsive signaling pathways have been identified in human skeletal muscle and are implicated in cellular metabolism and gene expression. Exercise/muscle contraction increases phosphorylation of stress and/or mitogenactivated protein kinases (MAPK), specifically the extracellular signal-regulated protein kinase (ERK) 1/2 (2) and p38 MAPK (61) . Signal transduction via metabolic pathways, including 5Ј-AMP-activated protein kinase (AMPK) (20) and protein kinase B (PKB)/Akt (51) , as well as Ca 2ϩ -or neuromuscular activation-sensing pathway through Ca 2ϩ calmodulin-dependent protein kinase II (CaMKII; see Ref. 47 ) is increased in response to acute exercise. Although the direct link between activation of these pathways and distinct metabolic and gene regulatory responses is only partly resolved, the adaptive response of these signaling pathways to chronic exercise training is unknown. Exercise-induced skeletal muscle signaling after training is attenuated and is a major contributing factor to muscular desensitization to endurance exercise (36, 69) . Long-term endurance training (Ն21 days) alters both metabolism (38) and cell signaling in human skeletal muscle (18, 46) . Short-term training also leads to training-induced changes in human skeletal muscle metabolism (11, 36, 38) . AMPK activity and phosphorylation is markedly attenuated after 10 days of intensified training (36) ; however, the effects of this training on the activation of stress and Ca 2ϩ and PKB/Akt signaling pathways in response to submaximal exercise have not been examined. Using an integrated physiological and molecular approach, we determined which of the multitude of signaling pathways activated in response to exercise-induced stress, metabolism, and neuromuscular inputs in human skeletal muscle responded to the intensified short-term training. We hypothesized that the signaling pathways and molecules displaying the greatest attenuation in response to exercise and training are responsible for adaptation in skeletal muscle. We studied signaling pathways involving AMPK, Akt, CaMKII, mammalian target of rapamycin (mTOR), ERK1/2, and p38 MAPK in skeletal muscle after acute exercise and training.
MATERIALS AND METHODS

Subjects
Nine male subjects (Table 1) were recruited for this study. Subjects were healthy nonsmokers, who participated in Ͻ2 h of exercise/wk. Subjects who had a peak pulmonary oxygen consumption (V O2peak) of Ͻ50 ml ⅐ min Ϫ1 ⅐ kg Ϫ1 were included in the study. Subjects were fully informed of the possible risks involved in the study before providing written consent. The study was approved by the Monash University Standing Committee on Ethics in Research Involving Humans and Karolinska Institutet Human Research Ethics Committee. The study was conducted according to the Helsinki Declaration.
Experimental Design
Participants completed a V O2peak test. Later (1 wk), subjects returned to the laboratory for the pretraining exercise trial. Trial days involved subjects cycling for 60 min at ϳ70% of their V O2peak.
During the trial, blood, expiratory gases, and skeletal muscle samples were taken. The 10-day cycle training regimen commenced ϳ7 days later and included four high-intensity intermittent interval training sessions. After the last training session (2 days), the second exercise trial was undertaken at the same absolute workload as the pretraining trial. A second V O2peak test was performed 2 days after the posttraining trial.
Peak Pulmonary Oxygen Consumption
V O2peak tests were completed on an electromagnetically-braked cycle ergometer (Lode B.V medical technology, Groningen, The Netherlands), essentially as described (24) . Participants cycled at an initial workload of 100 W, which increased to 150 W after 2.5 min, followed by a 25-W increase every 2.5 min until volitional exhaustion. Volitional fatigue was defined as the point at which the subjects' cadence decreased below 60 rpm and/or a respiratory exchange ratio (RER) of 1.12. V O2peak was determined as the subjects' highest V O2 that occurred in the last minute of the test. Peak power output (PPO) was also determined (24) . These parameters were used to determine the exercise intensities of 70, 75% and 90% of individual V O2peak for the relevant exercise tests and training sessions.
Throughout the maximal test and during portions of the subsequently described experimental trials and training sessions, subjects inspired air through a mouthpiece and low-resistance turbine attached to a MOXUS modular V O2 system (AEI Technologies, Pittsburgh, PA). The CO2 and O2 analyzers were calibrated before each test using gases (BOC, Melbourne, Australia) of known O2 (16%) and CO2 (4%) content. The K520 gas flow transducer (KL Engineering, Sylmar, CA) was calibrated using a 3-liter syringe (Hans Rudolph). Polar heart rate monitors (Polar Electro Oy, Kempele, Finland) were used in all exercise trials and training sessions.
Dietary and Exercise Control
Subjects were instructed to abstain from caffeinated products and alcoholic beverages 24 h before the exercise trials while consuming their normal diet, which they recorded in daily food diaries during the 3 days before the exercise trials. They were instructed to consume the same food or record any changes from the initial diet. Food diaries were analyzed for total energy consumption and the relative energy sources. This dietary control was effective, since diet and energy consumption were unchanged.
Exercise Trials
Subjects reported to the laboratory between 0600 or 0700 after an overnight fast (ϳ9 h). Upon arrival, subjects voided, and body Data are means Ϯ SE; n ϭ 9 experiments. V O2, volume of O2 consumed; RER, respiratory exchange ratio; V E, ventilation; FFA, nonesterified free fatty acid. *Significantly different from the same time point pretraining, P Ͻ 0.05. weight was measured. An indwelling catheter was then inserted in the antecubital vein of one forearm for continuous blood sampling and kept patent with regular flushing of 0.9% sterile saline. After a 15-min rest period, a resting blood sample was drawn. The thigh was then prepared for the muscle biopsies, where an area on the thigh over the vastus lateralis was cleaned and sterilized. Three biopsy sites ϳ5 cm apart were then anaesthetized with lignocaine (5% xylocaine; AstraZeneca, North Ryde, Australia). Three incisions were made through the skin and muscle fascia. The first muscle biopsy (150 -250 mg) was taken at rest from the most distal incision using the percutaneous needle biopsy technique with suction applied (17) . Following the initial biopsy, subjects rode at 72 Ϯ 1% V O2peak (164 Ϯ 9 W) for 60 min. During the ride, expiratory gas samples were collected for the 5 min preceding each blood sample. Blood samples were taken every 10 min during exercise. A second muscle biopsy was taken immediately (Ͻ20 s) after the completion of the 1-h ride. The subjects were then rested in a supine position and instructed to keep as still as possible for 3 after which the final biopsy was taken. Drinking water (8 ml/kg) was provided to subjects to consume over the duration of the trial, and any additional water requested was recorded and repeated for the posttraining trial. Muscle biopsies were immediately frozen in liquid nitrogen and stored at Ϫ80°C until analysis. Blood samples were spun at 2,500 g, and plasma was collected and stored at Ϫ30°C until analysis.
Training Protocol
Training consisted of 10 days of endurance training on the Lode cycle ergometer, including 4 days of high-intensity interval training as described (36) . Each subject performed the same relative level of exercise. Subjects rode at ϳ75% of their V O2peak for 45 min on days 1, 5, 6, and 10, for 60 min on day 3, and 90 min on day 8. High-intensity training took place on days 2, 4, 7, and 9, consisting of 6 ϫ 5-min intervals at ϳ90 -100% of subjects V O2peak with 2 min recovery at or below 40% V O2peak between exercise bouts. 
Analytical Techniques
Calculation of whole body substrate utilization. Whole body rates of carbohydrate and fat oxidation (g/min) were calculated from V CO2 and V O2 using the nonprotein RER (45) . The grams per minute substrate oxidation rates were then converted to micromoles per kilogram per minute rates as previously described (57) .
Blood analysis. Plasma was analyzed for glucose and lactate concentrations using the Synchron CX5 analyzer (Coulter, Fullerton, CA). Plasma free fatty acid (FFA) concentration was determined using a nonesterified FFA enzymatic colorimetric method, modified to a 96-well plate format (NEFAC code 279-75409; Wako, Tokyo, Japan).
Muscle tissue. Frozen muscle (50 mg) was freeze-dried and dissected free of blood and connective tissue. Muscle glycogen content was determined by standard fluorometric techniques (43) . Skeletal muscle protein was extracted in ice-cold buffer (20 mM Tris, pH 7.8, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 0.5 mM Na3VO4, 1% Triton X-100, 10% glycerol, 10 mM NaF, 0.2 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 1 mM dithiothreitol, 5 mM Na4O7P2, 1 mM benzamidine, 1 g/ml aprotinin, 1 g/ml leupeptin, and 1 M microcystin). All reagents were analytical grade (Sigma, St. Louis, MO), unless otherwise specified. Homogenates were rotated for 60 min at 4°C and centrifuged at 12,000 g for 10 min at 4°C, and protein concentration of the resulting supernatant was determined using a commercial kit (Bio-Rad, Richmond, CA).
Immunoblot analysis. Aliquots of muscle lysate were mixed with Laemmli sample buffer, and 40 g of total protein/sample were separated by SDS-PAGE using gradient (5-20%) gels. The glucose transporters (GLUT) 1 and 4 were separated on 10% SDS-PAGE gels. Following electrophoresis, proteins were transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA). Membranes were blocked in 10 mM Tris, 100 mM NaCl, and 0.02% Tween 20 (TBST) containing 5% nonfat milk for 2 h at room temperature, washed with TBST for 10 min, and then incubated with the appropriate primary antibody overnight at 4°C.
To determine the protein expression and phosphorylation, membranes were incubated with antibodies for 160 (Cell Signaling Technologies nos. 2317, 2211, and 4838), and phospho-S6 ribosomal protein kinase 1 Thr 389 (S6K1; Cell Signaling Technologies no. 9234). All membranes were normalized for loading with glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Santa Cruz no. sc 25778). Following incubation with the primary antibodies, membranes were washed with TBST and incubated with the appropriate secondary antibody for 1 h at room temperature, followed by washing in TBST. Immunoreactive proteins were detected using enhanced chemiluminescence (ECL) reagents (Amersham, Arlington, IL) and quantified by densitometric scanning. Horseradish peroxidase-conjugated goat anti-rabbit and anti-mouse immunoglobin G were from Bio-Rad Laboratories (Richmond, CA).
Statistical Analysis
Data are presented as means Ϯ SE for nine subjects unless otherwise stated. Statistical analysis of plasma glucose, lactate, and FFA concentrations, as well as changes in protein phosphorylation, were conducted using repeated-measures ANOVA (training ϫ time). Correlations were conducted using the Pearson correlation. Analysis was conducted using the statistical package SPSS 15.0 for Windows (SPSS). The results from the ANOVA were considered significant when P Ͻ 0.05. A Fisher's Least Significant Difference post hoc test was conducted to determine where specific differences occurred between results, with significance taken when P Ͻ 0.05. V O2peak, PPO, and protein expression data were compared with a paired t-test, with significant differences taken as P Ͻ 0.05.
RESULTS
Physiological Responses to Exercise
The intensified training protocol resulted in a number of physiological or systemic adaptations, including changes in aerobic exercise capacity, where whole body V O 2peak increased by 10% (P Ͻ 0.05; Table 1 ), corresponding to a 15% increase in PPO (P Ͻ 0.05; Table 1 ). Furthermore, 10 days intensified training also altered the physiological responses to submaximal exercise at the same absolute work rate (164 Ϯ 9 W). The participants exercised at 71 Ϯ 4 or 64 Ϯ 3% of pre-and posttraining V O 2peak , respectively. This was accompanied by reductions in mean heart rate and V E during the 60-min bout of cycling, decreasing from 164 Ϯ 4 to 151 Ϯ 4 beats/min and 60 Ϯ 4 to 57 Ϯ 4 l/min, respectively (P Ͻ 0.05; Table 2 ). RER (0.94 Ϯ 0.01) and V O 2 (2.4 Ϯ 0.1 l/min) were unchanged during exercise before and after training. Mean whole body substrate utilization rates during exercise demonstrated a shift to fat oxidation, where the mean rate of fat oxidation increased from 9.8 Ϯ 2.2 to 38.1 Ϯ 1.9 mol ⅐ kg Ϫ1 ⅐ min Ϫ1 (P Ͻ 0.01) after 10 days of training. A concomitant decrease in carbohydrate oxidation rate was not evident (188 Ϯ 8 vs. 184 Ϯ 7 mol ⅐ kg Ϫ1 ⅐ min Ϫ1 ). 
(E). Protein expression of GSK3␣ and -␤ was unchanged (D and F).
GAPDH was the loading control. Data are means Ϯ SE for n ϭ 8. {Significantly different from post-60, P Ͻ 0.05.
Blood glucose, lactate, and FFA were analyzed during the submaximal exercise trials. Blood glucose concentration was maintained at 5.3 Ϯ 0.1 and 5.1 Ϯ 0.1 mM (P Ͻ 0.05) during the pre-and posttraining exercise bouts, respectively. Blood lactate concentration increased rapidly at the onset of exercise and was maintained at 7.4 Ϯ 0.2 mM in the pretraining bout and 6.3 Ϯ 0.1 mM posttraining (P Ͻ 0.05; Table 2 ). Plasma FFA concentration decreased markedly after the onset of exercise, reaching a nadir of 0.20 Ϯ 0.01 mM at 10 min (Table  2) . FFA plasma concentrations started to return to resting levels after 30 min of exercise and occurred more rapidly in the untrained state (Table 2 ; P Ͻ 0.05). Resting FFA in the posttrained state was increased (0.33 Ϯ 0.01 vs. 0.48 Ϯ 0.01 mM; P Ͻ 0.05).
Skeletal Muscle Metabolic and Signaling Responses to Submaximal Exercise
Muscle glycogen content decreased in response to exercise and remained low during the 180 min of recovery (P Ͻ 0.05; Fig. 1 ). Resting muscle glycogen content increased after training from 600 Ϯ 63 to 970 Ϯ 54 mmol/kg dry wt (P Ͻ 0.05; Fig. 2 ). Glycogen utilization during pre-and posttraining exercise bouts amount to 370 Ϯ 64 and 320 Ϯ 63 mmol/kg dry wt, respectively. Glycogen content after exercise posttraining was the same as the pretraining resting muscle glycogen content (ϳ630 mmol/kg dry wt; Fig. 2) .
During the pretraining exercise bout, AMPK ␣-subunit Thr 172 phosphorylation was increased ϳ15-fold (P Ͻ 0.05; (Fig. 3A) . Similarly, exercise increased ACC phosphorylation ϳ14-fold in the pretrained state and 5-fold in the posttraining state (Pearson r ϭ 0.73; P Ͻ 0.001; Fig. 2C ; P Ͻ 0.01). AMPK and ACC expression was unaltered by training (Fig. 2, B and D) . AS160 phosphorylation was effected by both training and exercise (training status ϫ time interaction; P Ͻ 0.05; Fig. 3A) . Pretraining AS160 phosphorylation was not altered by the exercise bout but increased significantly after 3 h of recovery (Fig. 3B) . After the 10-day training regimen, AS160 phosphorylation was unchanged in response to the exercise bout or 3 h of recovery (Fig. 3A) . AS160 protein expression was increased 37 Ϯ 7% after training (P ϭ 0.06; Fig. 3B ). GLUT4 protein was increased 64 Ϯ 6% in response to the training regimen (P Ͻ 0.01; Fig. 3C ). Conversely, GLUT1 was undetected in skeletal muscle, which is in agreement with previous investigators (21) .
Akt/PKB phosphorylation was unaltered in response to exercise or training (Fig. 4, A and B) . Akt phosphorylation on Thr 308 (P ϭ 0.12; Fig. 4A ) and Ser 473 (P ϭ 0.16; Fig. 4B ) tended to be reduced after training. Akt protein expression was unaltered between pre-and posttraining conditions (data not shown). GSK3␣ phosphorylation was unaffected by exercise either before or after the 10 days of training (Fig. 4C) . GSK3␤ phosphorylation was unaffected by exercise before training (Fig. 4E) . After 10 days of training, GSK3␤ phosphorylation was more responsive to exercise and recovery (training effect, P ϭ 0.16; Fig. 4E ), where exercise increased phospho-GSK3␤ 22%, which, following 3 h of recovery, drops to 30% of the resting levels (P Ͻ 0.05; Fig. 4E ). The expression of GSK3␣ and -␤ was unchanged (Fig. 4, D and F) .
Phosphorylation of mTOR at Ser 2448 was increased (121%) in response to the cycling exercise bout before the training regimen, but overall this phosphorylation for all time points was less than that during posttraining exercise (P Ͻ 0.05; Fig. 5A ). Despite the total increase in mTOR phosphorylation (63%), posttraining exercise induced a further 58% increase in phosphorylation (P Ͻ 0.01; Fig. 5A ). mTOR expression increased 166% in response to training (P Ͻ 0.01; Fig. 5B ). Acute exercise increased S6K1 phosphorylated in response to exercise pretraining, and this response was attenuated in response to training such that after 3 h, or at recovery, S6K1 phosphorylation was reduced compared with all time points (P Ͻ 0.05; Fig. 5C ). Cycle exercise pretraining increased phosphorylation of the ribosomal protein S6 on Ser 240/244 , which returns to baseline levels after recovery (P Ͻ 0.01; Fig.  5D ). After 10 days of training, S6 Ser 240/244 phosphorylation was substantially reduced (training, time, and training ϫ time, P Ͻ 0.01; Fig. 5D ). S6 Ser 235/236 phosphorylation was reduced after 10 days of training (P Ͻ 0.01; Fig. 5E ). S6 Ser 235/236 phosphorylation correlated with ERK1/2 phosphorylation (Pearson's r ϭ 0.66; P Ͻ 0.001), but not S6K1 phosphorylation. Training was without effect on S6 protein expression (Fig. 5F ). Exercise increased phosphorylation of p38 MAPK both before and after training (P Ͻ 0.05 for the time effect; Fig. 6A ). Phosphorylation of ERK1/2 MAPK was increased after exercise in the pretraining state, with its activation drastically reduced in response to the exercise posttrained state (P Ͻ 0.01; Fig. 6C ). Protein expression of ERK1/2 MAPK and p38 MAPK were unchanged after 10 days of training (Fig. 6, B  and D) .
Exercise-induced phosphorylation of Thr 286 of total CaMKII was increased by 66% pretraining (P Ͻ 0.05; Fig. 7A ). Similarly, CaMKII had a 44% increase in phosphorylation in response to posttraining exercise (P Ͻ 0.05; Fig. 7A ). Protein expression of CaMKII was increased 48 Ϯ 6% after 10 days of intensified training (P Ͻ 0.05; Fig. 7B ). PLB, a substrate of CaMKII, demonstrated a similar phosphorylation pattern in response to exercise pre-and posttraining (Pearson r ϭ 0.83; P Ͻ 0.01), which increased 135 Ϯ 7 and 125 Ϯ 8% immediately after exercise (P Ͻ 0.05; Fig. 7C) , with no changes in PLB expression (Fig. 7D) .
DISCUSSION
Here we provide evidence that endurance exercise leads to divergent signaling responses pre-and postintensified endurance training in the AMPK, ERK1/2 MAPK, and mTOR pathways. However, the exercise-induced signaling in CaMKII and p38 MAPK pathways is unaffected by short-term training. These signaling changes occurred in concert with attenuated whole body and muscle metabolite responses to exercise.
AMPK is a metabolic master switch that, when activated, switches off energy-consuming pathways and activates energyproducing pathways (65) . AMPK activity and phosphorylation of Thr 172 on the ␣-subunit isoform is increased in response to exercise intensity (20, 56) and attenuated by training (18, 36) in human skeletal muscle. We and others (36) report the AMPK ␣-subunit is phosphorylated in response to exercise, and markedly attenuated posttraining. The reduced AMPK signaling may be due to the increased glycogen content posttraining (55, 66) , but this should be viewed with caution, since identical signal attenuation has been reported in subjects with low starting glycogen levels posttraining (36) . Collectively, AMPK signaling regulates gene expression (55) and RNA translation (32), a key response in early training adaptations to endurance training.
The Akt substrate AS160/TBC1D4 plays a role in GLUT4 translocation and glucose transport (10) . Whereas the PAS antibody recognizes molecules phosphorylated by Akt and AMPK (14 -16, 58) , our methods to detect phospho-AS160 have been validated (14 -16) . Exercise and training interacted to alter AS160 phosphorylation only after 3 h of recovery pretraining. AS160 protein expression posttraining tended to increase (37%), which may account for the reduction in phosphorylation posttraining, as demonstrated earlier (19) . The marked elevation in AS160 phosphorylation 3 h after the pretraining exercise bout potentially disassociates AS160 phosphorylation from Akt (30, 53) and AMPK (59) . This may be physiologically relevant for GLUT4 translocation and glucose uptake, especially in the pretraining exercise bout when muscle glycogen content is low (ϳ230 mmol/kg dry wt). Nevertheless, increased GLUT4 protein content may also account for the exercise training-induced improvement in glucose uptake (31, 41) .
Akt is a Ser/Thr kinase that plays a pivotal role in glucose uptake (AS160), glycogen synthesis (GSK3␣), and protein synthesis (mTOR, GSK3␤; see Refs. 4, 9, and 39). Akt phosphorylation was unaltered in response to exercise either pre-or posttraining, despite activation of numerous of its substrates, as previously shown by some (35, 61, 67) , but not all (14, 15, 51, 63, 64) , workers. These discrepancies may arise from the different exercise protocols, dietary controls, and/or overall fitness levels of the subjects studied. Our data provide evidence that Akt may still be important in muscle adaptation to endurance exercise, since there were strong trends for lower overall phosphorylation at Ser 473 and Thr 308 posttraining. Further evidence for the importance of Akt signaling in endurance exercise adaptation is provided by the change in GSK3␤ sensitivity, which regulates RNA translation via eukaryotic initiation factor 2B (60). GSK3␣ is implicated in glycogen synthase regulation, but neither exercise nor training altered phosphorylation. Although this was unexpected, glycogen synthesis can be promoted without increases in GSK3␣ phosphorylation (8) . Furthermore, over the duration of both pre-and postexercise trials, glycogen resynthesis was not altered.
Protein complexes involving mTOR sense diverse signals and elicit multiple responses, including mRNA translation, nutrient metabolism, cell growth, and ribosomal biogenesis (13, 54) , as seen in muscle hypertrophy (4, 14) . mTOR is regulated by many pathways, including Akt, AMPK, and p38 MAPK (5, 6, 16, 32, 33) . We found that mTOR Ser 2448 was phosphorylated immediately after exercise, consistent with other studies (35, 42, 63) . This phosphorylation pattern was maintained and augmented posttraining, but this may be a consequence of increased mTOR protein expression compared with the pretraining state. The mTOR pathway is activated by Akt and p38 MAPK signaling and inactivated by AMPK signaling (5, 16, 32, 33) . Pretraining exercise-induced p38 MAPK phosphorylation could contribute to mTOR activation, which could override the exercise-induced phospho-AMPK effect on mTOR. The phospho-AMPK inhibition of mTOR (5, 16) in response to exercise was reduced posttraining, possibly allowing greater activation of mTOR from other signaling inputs.
mTOR has been implicated in protein synthesis via its regulation of S6K1 and S6 to increase translation of mRNA (reviewed in Ref. 32) . We demonstrated that S6K1 Thr 389 is phosphorylated immediately after exercise, which is markedly attenuated posttraining, a finding consistent with some (63), but not all (14, 35) , studies. These discrepancies are most likely due to the different experimental protocols and subjects studied. Activation of S6K1 is divergent from phospho-mTOR, (44, 50) . Our data highlight the mTOR pathway in the regulation of muscle function and adaptation in endurance exercise and training.
Different modes of exercise/contraction, mechanical stress, and training status increase MAPK signaling (14, 61, 68, 69) . We found an exercise-and training-specific response in ERK1/2, but not p38, phosphorylation in accordance with some (68, 69), but not all (14, 40) , studies. The ERK1/2 pathway, which is sensitive to exercise intensity (62) , has been proposed to play a role in the formation of slow muscle fibers (27) and in the general stress response (14) . Our data show that, posttraining, the exercise-induced ERK1/2 activation is almost abolished, which occurred in conjunction with a drop in relative exercise intensity. With respect to the p38 MAPK pathway, our data showing no attenuation of phospho-p38 MAPK after training were unexpected. High mechanical stress induces p38 MAPK phosphorylation (68) , which may partly explain the exercise-induced p38 MAPK phosphorylation. Our results suggest that the maintained activation of p38 MAPK in the posttraining exercise period plays a role in the maintenance of muscle adaptations.
CaMKII has been identified as the main multifunctional Ca 2ϩ -calmodulin dependant kinase expressed in human skeletal muscle (47, 48) and is implicated in contraction-and/or Fig. 8 . Schema of proposed signaling pathway and convergence on the mTOR pathway in the regulation of endurance training adaptations in human skeletal muscle. The interactions proposed in this schema demonstrate that exercise alone activates AMPK, CaMKII, ERK1/2, p38 MAPK, mTOR, and possibly Akt. All of these pathways converge on the mTOR pathway, which ultimately regulates protein translation and adaptive responses to exercise training. AS160, 160-kDa Akt substrate; eIF-4E, eukaryotic initiation factor 4E; 4E-BP1, eIF-4E binding protein 1; GSK, glycogen synthase kinase; p38, 38-kDa mitogenic-activated protein kinase. Solid arrows, activation of target; dotted arrows, possible activation pathways; solid boundary squares, effected by acute exercise and training; dotted boundary square, possible protein effected by acute exercise and training; solid boundary circle, effected by acute exercise, but unaffected by training.
exercise-mediated changes in carbohydrate metabolism, gene transcription, protein synthesis, and ion homeostasis (46 -49) . Our data demonstrate that, in the pre-and posttraining state, CaMKII is transiently phosphorylated on Thr 287 in response to exercise and returns to resting levels after 3 h of recovery, which has not been demonstrated previously. Despite the identical phosphorylation patterns of CaMKII, training induced an ϳ50% increase in total CaMKII expression, consistent with an earlier report after 3 wk of single leg training (46) . We assessed phosphorylation of CaMKII substrate PLB to determine the in vivo kinase activity (48) and show PLB phosphorylation directly correlates with phospho-CaMKII. CaMKs play an important role in ion homeostasis during excitation-contraction coupling (37, 51) , but mechanistic data linking Ca 2ϩ and CaMKII to gene expression are elusive, despite the coupling between CaMKII activity/phosphorylation with activation of serum response factor, class II histone deacytlases, and calicneurin-nuclear factor activated T cells (34, 48) . Our data highlight that Ca 2ϩ signaling during endurance exercise via CAMKII may play a role in the maintenance training adaptations, such as the transformation of fast to slow muscle fiber types in response to chronic endurance training (3, 70) .
Here we report key signaling pathways are responsive to acute exercise and short-term intensified endurance training (Fig. 8) . We highlight a potential role for the mTOR-protein synthesis pathway and the convergence of metabolic and mitogenic/gene regulatory signals along this pathway. The general and exercise-specific stress signals communicated via these complex and interconnected pathways ultimately influence gene and protein expression, which may account for short-and long-term phenotypic changes in human skeletal muscle in response to endurance exercise training. In conclusion, 10 days of intensified cycling training induced whole body physiological changes and skeletal muscle adaptations to exercise, which were accompanied by divergent desensitization of key kinases in metabolic, stress, and Ca 2ϩ -sensitive signaling pathways implicated in skeletal muscle adaptation to endurance exercise training. Phosphorylation and in vivo activity of AMPK, ERK1/2, and mTOR was reduced or even abolished in response to exercise posttraining, whereas exercise induced signaling via CaMKII and p38 MAPK posttraining. Taken together, these data highlight the signaling pathways that are sensitive to relative exercise intensity (general stress; AMPK, ERK1/2, and mTOR) and absolute exercise intensity (exercise-specific stress; CaMKII and p38 MAPK), providing molecular mechanisms for the rapid functional adaptation and maintenance of training-induced responses.
